These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
832 related articles for article (PubMed ID: 23801738)
1. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease. Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738 [TBL] [Abstract][Full Text] [Related]
2. Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation. Kantor S; Szabo L; Varga J; Cuesta M; Morton AJ Brain; 2013 Jul; 136(Pt 7):2147-58. PubMed ID: 23801737 [TBL] [Abstract][Full Text] [Related]
3. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease. Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107 [TBL] [Abstract][Full Text] [Related]
4. A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease mice. Kantor S; Varga J; Morton AJ Neuropharmacology; 2016 Jun; 105():298-307. PubMed ID: 26805423 [TBL] [Abstract][Full Text] [Related]
6. Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington's Disease. Vas S; Casey JM; Schneider WT; Kalmar L; Morton AJ Neurotherapeutics; 2020 Jul; 17(3):1075-1086. PubMed ID: 32297185 [TBL] [Abstract][Full Text] [Related]
7. Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease. Batcha AH; Greferath U; Jobling AI; Vessey KA; Ward MM; Nithianantharajah J; Hannan AJ; Kalloniatis M; Fletcher EL Neurobiol Dis; 2012 Mar; 45(3):887-96. PubMed ID: 22198376 [TBL] [Abstract][Full Text] [Related]
8. Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice. Kantor S; Varga J; Kulkarni S; Morton AJ Neurotherapeutics; 2017 Oct; 14(4):1120-1133. PubMed ID: 28653279 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451 [TBL] [Abstract][Full Text] [Related]
10. Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice. Aguilar DD; Strecker RE; Basheer R; McNally JM J Neurophysiol; 2020 Jan; 123(1):22-33. PubMed ID: 31747354 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221 [TBL] [Abstract][Full Text] [Related]
12. Sleep/Wake Physiology and Quantitative Electroencephalogram Analysis of the Neuroligin-3 Knockout Rat Model of Autism Spectrum Disorder. Thomas AM; Schwartz MD; Saxe MD; Kilduff TS Sleep; 2017 Oct; 40(10):. PubMed ID: 28958035 [TBL] [Abstract][Full Text] [Related]
13. Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease. Vas S; Nicol AU; Kalmar L; Miles J; Morton AJ Neurobiol Dis; 2021 Jul; 155():105367. PubMed ID: 33848636 [TBL] [Abstract][Full Text] [Related]
14. An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease. Zarringhalam K; Ka M; Kook YH; Terranova JI; Suh Y; King OD; Um M Behav Brain Res; 2012 Apr; 229(1):216-25. PubMed ID: 22266926 [TBL] [Abstract][Full Text] [Related]
15. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease. Dufour BD; McBride JL Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424 [TBL] [Abstract][Full Text] [Related]
16. Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice. Bolivar VJ; Manley K; Messer A Brain Res; 2004 Apr; 1005(1-2):29-35. PubMed ID: 15044061 [TBL] [Abstract][Full Text] [Related]
17. Pilot Validation of Ambulatory Activity Monitors for Sleep Measurement in Huntington's Disease Gene Carriers. Maskevich S; Jumabhoy R; Dao PDM; Stout JC; Drummond SPA J Huntingtons Dis; 2017; 6(3):249-253. PubMed ID: 28968241 [TBL] [Abstract][Full Text] [Related]
18. β oscillation during slow wave sleep and rapid eye movement sleep in the electroencephalogram of a transgenic mouse model of Huntington's disease. Jeantet Y; Cayzac S; Cho YH PLoS One; 2013; 8(11):e79509. PubMed ID: 24244517 [TBL] [Abstract][Full Text] [Related]
19. Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Hu WP; Li JD; Zhang C; Boehmer L; Siegel JM; Zhou QY Sleep; 2007 Mar; 30(3):247-56. PubMed ID: 17425220 [TBL] [Abstract][Full Text] [Related]
20. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease. Ouk K; Aungier J; Morton AJ Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]